Neulasta Coupon First Step co-pay coupon program

The Amgen FIRST STEP™ Progam is a medical benefit co-pay coupon program to help commercially insured eligible patients with their deductible, co-insurance, and/or co-pay requirements for Neulasta®(pegfilgrastim), Nplate®(romiplostim), and XGEVA™(denosumab). 100% of an eligible patient's combined co-payment, coinsurance or deductible will be covered for the patient's first injection of the Amgen product covered by the AMGEN FIRST STEP™ Program. For all subsequent injections, Amgen will pay the patient's combined out-of-pocket co-payment, coinsurance or deductible amount in excess of $25 per injection for a total program benefit up to $5,000 per patient, per 6-month period. The 6-month program period runs from January 1 through June 30 and July 1 through December 31.

Neulasta (pegfilgrastim) is a colony stimulating factor. It is a man-made form of a protein (amino acid) that stimulates the bone marrow and promotes the growth of white blood cells called neutrophils in your body. White blood cells help your body fight against infection. Neulasta is used to prevent neutropenia, a lack of certain white blood cells caused by receiving chemotherapy.